May 7, 2026 06:40PM
May 7, 2026 04:01PM
Mar 31, 2026 06:16AM
Mar 30, 2026 04:01PM
Nov 10, 2025 04:05PM
Aug 14, 2025 05:45PM
Aug 14, 2025 04:05PM Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
May 13, 2025 07:55AM
May 13, 2025 06:19AM
May 12, 2025 08:00AM
Mar 3, 2025 04:26PM
Mar 3, 2025 08:00AM
Nov 14, 2024 08:00AM
Aug 12, 2024 08:40AM Annexon, Inc. (ANNX) Reports In-Line Q2 EPS
Aug 12, 2024 08:00AM
May 13, 2024 08:00AM
Apr 5, 2024 07:00PM
Mar 26, 2024 04:05PM
Nov 13, 2023 06:31AM
Nov 13, 2023 06:30AM
Nov 13, 2023 06:30AM Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
Aug 7, 2023 06:52AM
Aug 7, 2023 06:30AM
May 8, 2023 05:20PM
May 8, 2023 04:01PM
Mar 6, 2023 06:30AM
Mar 6, 2023 06:30AM
Nov 3, 2022 06:30AM Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
Nov 3, 2022 06:30AM
Aug 8, 2022 04:01PM
Aug 8, 2022 04:01PM
May 9, 2022 04:01PM
May 9, 2022 04:01PM
Mar 2, 2022 07:13AM
Mar 1, 2022 04:01PM Annexon Biosciences Announces Program Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 1, 2022 04:01PM
Nov 9, 2021 04:01PM
Nov 9, 2021 04:01PM
Aug 16, 2021 04:01PM
Aug 16, 2021 04:01PM
May 17, 2021 04:05PM
May 17, 2021 04:05PM Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results
Mar 25, 2021 07:00AM
Mar 25, 2021 07:00AM
Nov 16, 2020 04:01PM
Nov 16, 2020 04:01PM
Sep 8, 2020 04:01PM
Sep 8, 2020 04:01PM

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All